Novartis to Squeeze Out MorphoSys Minority Shareholders, Initiate Delisting

MorphoSys AG ((FSE: MOR, NASDAQ:MOR) today announced that the company has entered into a delisting agreement with Novartis BidCo AG and Novartis AG following the successful closing of the acquisition

BenzingaJun 20 03:13 ET

MorphoSys Delisting From Frankfurt Stock Exchange, Nasdaq Expected to Take Place in 3Q

MorphoSys Delisting From Frankfurt Stock Exchange, Nasdaq Expected to Take Place in 3Q

Dow JonesJun 20 02:35 ET

Novartis to Offer EUR68 a Share in Cash to Minority MorphoSys Shareholders

Novartis to Offer EUR68 a Share in Cash to Minority MorphoSys Shareholders

Dow JonesJun 20 02:33 ET

Novartis Holds Around 91.04% of MorphoSys as of Thursday

Novartis Holds Around 91.04% of MorphoSys as of Thursday

Dow JonesJun 20 02:32 ET

Ad Hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG's Minority Shareholders

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to me

AccesswireJun 20 02:20 ET

MorphoSys to Leave Deutsche Börse's MDAX, TecDAX Indices

Deutsche Börse (DB1.F) said Tuesday that MorphoSys (MOR.F) will exit its MDAX and TecDAX indices, effective June 24. The biopharmaceutical company will leave the indices as its free float dropped bel

MT NewswiresJun 19 01:46 ET